+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Europe Beta-Glucan Market - Growth, Trends and Forecasts (2017 - 2022)

  • ID: 4114975
  • Report
  • Region: Europe
  • 80 pages
  • Mordor Intelligence
1 of 4


Market Insights

The Europe beta-glucan market is expected to witness a CAGR of XX % during the forecast period of 2017 - 2022. The market, estimated at USD XX billion as of 2017, is projected to reach USD XX billion by 2022. The European region accounted for the largest share of the global beta-glucan market, in 2015.

Market Dynamics

Factors driving the beta-glucan industry are the increasing consumption of nutraceuticals and functional food, its usage as immunomodulator (immunomodulators are chemical agents that modify the immune response) and increased usage as fat substitutes. The increased usage as a fat substitute and as yeast additive in biodiesel production, are the other key factors propelling the beta-glucan industry growth. High cholesterol levels, rising obesity, and diabetes have increased the usage of beta-glucan in medicines.

In Europe, the market for beta-glucan is driven by an increase in the demand for health and wellness products among consumers. Europe is one of the world’s largest markets for beta-glucan, which is used as a functional ingredient and also in nutraceuticals. The manufacturers in Europe are marketing beta-glucan containing products as those that prevent food-related non-communicable disease and make the daily diet healthier. The extent and cost of diet-related health problems have diverted the European government's attention towards dietary solutions and has also encouraged the extensive marketing of beta-glucan-derived from cereals, which are perceived as healthy, like oats. The age factor, in Europe, has also impacted the consumer’s willingness to try out novel beta-glucan products. Beta-glucan is a significant functional ingredient that has various medical advantages. Its role in controlling hyperlipidemia and hyperglycemia is unmatchable. In 2010, the European Food Safety Authority (EFSA) had approved beta-glucan health claims, after the Swiss CreaNutrition AG submitted a claim on oat beta-glucan’s blood cholesterol lowering/reducing properties, which increased the growth prospects of the beta-glucan market in Europe

The shortage of raw material, like molasses, due to its increasing application in wine blending and industrial applications, is expected to hinder the beta-glucan market growth. The production of yeast is dependent on the availability of molasses. The yeast market is facing tough competition from other industries for raw materials. The bio-fuel industry is also threatening the growth of the yeast margin as it operates on high margins. The availability of other feasible substitutes is also hampering the beta-glucan industry.

Market Segmentation

The human body does not produce beta-glucan, naturally. Hence, the only way to get is through outside sources, such as baker's yeast, shiitake mushrooms, and cereal grains that include barley, oats, rye, and wheat. Hence, beta-glucan is segmented by source type into cereal, yeast, mushroom, bacteria. By type, the market is segmented as soluble and insoluble. The cereal segment accounted for 44.2% share of the beta-glucan market, in 2016, and is expected to register a healthy CAGR of 6.8%. This segment is further segregated into oats barley and others such as wheat, sorghum, rye, of which, oats is the fastest-growing segment, with a CAGR of 6.5%. By type, the market has been segmented into soluble beta-glucan and insoluble beta-glucan, with the soluble beta-glucan segment having the maximum share.

Regarding applications, the beta-glucan market is segmented into food & beverages, bakery, dairy & functional food products, nutraceuticals and others, including cosmetics, biodiesel, and animal feed. The food & beverage segment leads the overall market, currently, which holds around 25% of the beta-glucan market.

Regional Analysis

The Europe beta-glucan market is geographically divided into Germany, the United Kingdom, France, Spain, Russia, Italy and others. France has the highest share accounting to 19% of the total beta-glucan market of Europe, followed by Germany and the United Kingdom, with 15.3% and 12.5%, respectively.

Trends that are driving the market growth include expansion and product enhancement strategies by various players. The food industry is constantly witnessing innovations in the healthy-food category, in order to meet the rising demand for natural additives. There is also an advanced nutraceutical market that has many product offerings, with ß-glucan as the primary ingredient.

Competitive Landscape

The prominent players present in the Europe beta-glucan market are:

Leiber GmbH
Biothera Inc
Royal DSM N.V.

AIT Ingredients (The Soufflet Group)
Associated British Foods Plc
TLesaffre Human Care
Biotec Pharmacon ASA (Biotec BetaGlucans AS)
Tate & Lyle Oat Ingredients
ABF Ingredients
Biocosmética EXEL
AHD International
Due to the presence of several players in the market, there is high competition, with the players wanting to capture major market shares. Hence, the companies exert pressure on each other and try to limit their competitor's profitability. However, high economic base and high growth rate increase the competitive rivalry in the industry. Stringent exit barriers of the industry and product innovations make the competition high.

Realizing a huge opportunity in the wound healing business, Biotec Pharmacon ASA has tied up with top homecare companies, which are large organizations with central purchasing functions, and the distributor Rogg Verbandstoffe GmbH & Co.KG, for sales to physician offices and their connected pharmacies. The company is focusing on increasing the market for its product Woulgan®, a type of Bioactive Beta-Glucan gel used for hard-to-heal wounds.

Investment Opportunity

Currently, the beta-glucan segment is witnessing a large-scale demand, owing to the change in eating patterns, which results in the rise in consumption of processed and functional foods. There are huge opportunities in the cosmetic and pharmaceutical industries, due to the growing application of beta-glucan.

Key Deliverables in the Study

Market analysis for the Europe beta-glucan market, with region-specific assessments and competition analysis on a regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the Europe beta-glucan market on a regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions where this industry is growing and also identify the regions that are still untapped.
Note: Product cover images may vary from those shown
2 of 4


1. Introduction
1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Market Definitions

2. Research Approach and Methodology
2.1 Introduction
2.2 Research Design
2.3 Study Timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Modelling
2.4.4 Expert Validation

3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers Usage as Immunomodulator Usage in Nutraceutical and Functional Food Industry Usage as Yeast Additive in Biodiesel Production
3.1.2 Restraints Shortage of Major Raw Materials (Molasses) Easy Availability of Feasible Substitutes
3.1.3 Opportunities Increasing Usage of Beta Glucan in the Processed Food Industry Application in Cosmetic and Pharmaceutical Industry
3.1.4 Porter's Five Forces Analysis Bargaining Power of Suppliers Bargaining Power of Buyers Threat of New Entrants Threat of Substitute Products and Services Degree of Competition

4. Market Segmentation
4.1 By Source Type
4.1.1 Cereals Oats Barley Others(Wheat, Ray, Shorgum)
4.1.2 Yeast
4.1.3 Mushroom
4.1.4 Bacteria
4.1.5 Others
4.2 By Type
4.2.1 Soluble
4.2.2 Insoluble
4.3 By Application
4.3.1 Food & Beverages
4.3.2 Bakery Product
4.3.3 Dairy Product
4.3.4 Nutraceuticals
4.3.5 Cosmetics
4.3.6 Biodiesel
4.3.7 Animal Feed
4.3.8 Others
4.4 By Geography
4.4.1 Europe Spain UK France Germany Russia Italy Others

5. Competitive Landscape
5.1 Strategies Adopted by Key Players
5.2 Most Active Companies in the Past Five Years
5.3 Market Share Analysis

6. Company Profiles
6.1 Associated British Foods Plc
6.2 Tate & Lyle Oat Ingredients
6.3 Lesaffre Human Care
6.4 Lallemand
6.5 Biothera Inc
6.6 Garuda International INC
6.7 Alltech
6.8 Royal DSM N.V.
6.9 Cargill
6.10 AIT Ingredients (The Soufflet Group)
6.11 Biotec Pharmacon ASA (Biotec BetaGlucans AS)
6.12 ABF Ingredients
6.13 Naturex
6.14 Leiber GmbH
6.15 Biorigin
6.16 CreaNutrition
6.17 Biocosmética EXEL
6.18 AHD International
6.19 Herbalife

7. Appendix
7.1 Disclaimer
7.2 Sources
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Xena Bio Herbals"
Note: Product cover images may vary from those shown